跳至主要内容
临床试验/EUCTR2018-004352-38-NL
EUCTR2018-004352-38-NL进行中(未招募)1 期

ocal Application of Pilocarpine for Relieving Dry Mouth Complaints: A randomized controlled pilot trial - xero2019

Centraal Ziekenfonds (CZ) health insurance company0 个研究点目标入组 24 人开始时间: 2019年2月25日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • = 70 years of age • Clinical diagnosis of chronic dry mouth defined as a Numeric Rating Scale (NRS) score = 5 (scale 0 – 10, with 0 = no dry mouth and 10= worst possible dry mouth) on severity of xerostomia for more than 3 months.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 24

排除标准

  • Existence of cognitive impairment and/or diagnosis of dementia appraised by treating physician • Inability to fill out the questionnaires due to other reasons • Prior radiation therapy of the head-and-neck region • Known m. Sjögren disease • Contra-indications for parasympathicomimetics (uncontrolled asthma, acute heart failure, active peptic ulceration, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.

研究者

发起方
Centraal Ziekenfonds (CZ) health insurance company

相似试验